Nutex Health, Inc. plans to file its Form 10-Q for the second fiscal quarter ended June 30, 2026, on Thursday, Aug. 6, 2026, after the market close. The company will issue a corresponding press release summarizing its financial results on the same day. Nutex Health is a physician-led, integrated healthcare delivery system comprising 27 micro hospitals and hospital outpatient departments across 12 states, along with primary care-centric, risk-bearing physician networks.

Nutex Health will host its earnings conference call on Friday, Aug. 7, 2026, at 9:30 a.m. CT to discuss its financial performance and provide a business update. The call will offer insights into the company's operations across its three divisions: Hospital, Population Health Management, and Real Estate.

Conference Call Details

Participants can join the call via the guest dial-in numbers or use the Call me™ link for immediate telephone access. The Call me™ link will be activated 15 minutes before the scheduled start time. Following the event, a transcript and recording will be available on the company's website under the "Investor Materials" section.

Company Overview

Headquartered in Houston, Texas, Nutex Health operates through three main divisions. The Hospital Division owns, develops, and operates 27 facilities, including micro-hospitals and specialty hospitals. The Population Health Management Division owns provider networks and provides management services through its Management Services Organization. The Real Estate Division manages real estate entities involved in the development and construction of hospital facilities, leasing land and buildings to hospital entities.

B. Riley Securities analyst Anderson Schock has initiated coverage on Nutex Health with a Buy rating and a price target of $290. The rating highlights the firm's positive outlook on the company's future performance.

Analyst Details

The coverage initiation was led by Anderson Schock, an analyst at B. Riley Securities. The Buy rating suggests that the stock is expected to outperform the market average.

Price Target

B. Riley Securities set a price target of $290 for Nutex Health. This target indicates the firm's projection for the stock's potential upside over a specific period.